Product Code: PHA0525
Title:
Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029
Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.
The global immunochemistry reagents, analyzers and test kits market is estimated to have reached $23bn in 2018 and is expected to grow at a CAGR of 8.5% in the first half of the forecast period. The Disease Specific Test submarket held 42% of the global immunochemistry reagents, analyzers and test kits market in 2018.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 184-page report you will receive 57 tables and 75 figures - all unavailable elsewhere.
The 184-page report provides clear detailed insight into immunochemistry reagents, analyzers and test kits market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
- Global Immunochemistry Reagents, Analyzers and Test Kits Market forecasts from 2019-2029
Along with revenue prediction for the overall world market, you see forecasts to 2029 for these submarkets:
- Immunochemistry reagents and tests kits
- Immunochemistry analysers
The study also forecasts immunochemistry reagents and tests kits subsectors:
- Anaemia/Vitamin tests
- Disease specific tests
- Drugs of abuse/toxicology tests
- Therapeutic drug monitoring
- Endocrinology tests
- Rapid tests
Our report provides revenues to 2029 for the sub-segments of the immunochemistry analysers, which includes:
- Chemiluminescence analysers
- ELISA analysers
- Immunofluorescence analysers
- Radioimmunoassay analysers
This report forecasts the size of the immunochemistry market in these regional and national market:
- North America: US & Canada
- Europe: Germany, France, Italy, Spain, UK, Rest of Europe
- Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East and Africa: South Africa, GCC Countries, Rest of MEA
Each regional market forecast is further segmented into Immunochemistry Reagents and Test Kits Market and Immunochemistry Analyzers Market.
Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies:
- Abbott
- bioMerieux
- Danaher
- Fujirebio
- Ortho Clinical Diagnostics
- Roche
- Siemens
- Sysmex Corporation
- Thermo Fisher Scientific
- Trivitron Healthcare Pvt. Ltd.
Qualitative analysis of the generic drugs market:
- SWOT Analysis of the Global Immunochemistry Reagents, Analyzers and Test Kits Market
- Discussion on factors that drive and restrain the Global Immunochemistry Reagents, Analyzers and Test Kits Market
Key Questions Answered by This Report:
- How is the immunochemistry market evolving?
- What is driving and restraining the immunochemistry industry?
- What are the market shares of the main segments of the immunochemistry field in 2018?
- How will each immunochemistry submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
- How will the market shares for immunochemistry submarkets develop from 2019-2029?
- What will be the main sales drivers for the overall market from 2019-2029?
- How will the market shares of the top regional markets change by 2029, and which will lead the market then?
- Who are the leading companies, and what are their prospects from 2018?
- What are the trends for M&A activity, consolidation for existing players and the potential for new market entrants?
- How will that industry evolve between 2018 and 2029? Where does it head?
Visiongain's study is intended for anyone requiring commercial analyses for the Global Immunochemistry Reagents, Analyzers and Test Kits Market. You find data, trends and predictions.
Buy our report todayGlobal Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.
Visiongain is a trading partner with the US Federal Government.
Table of Contents
1. Report Overview
- 1.1 Sector Highlights
- 1.2 Why You Should Read this Report
- 1.3 How this Study Delivers Information
- 1.4 Main Questions Answered by Our Analysis
- 1.5 Who is This Report For?
- 1.6 Research and Analysis Methods
- 1.7 Frequently Asked Questions (FAQ)
- 1.8 Associated Visiongain Reports
- 1.9 About Visiongain
2. Introduction
- 2.1 What are In Vitro Diagnostic (IVD) Tests?
- 2.2 Types of IVD Tests
- 2.2.1 Point of Care Tests
- 2.2.2 Clinical Chemistry
- 2.2.3 Haematology
- 2.2.4 Microbiology
- 2.2.5 Genetic Testing
- 2.2.6 Immunochemistry
- 2.3 The Immune System
- 2.3.1 What is an Antigen?
- 2.3.2 What is an Antibody?
- 2.3.3 Antigen-Antibody Interaction
- 2.3.4 Affinity and Avidity of Antigen-Antibody Interactions
- 2.4 Polyclonal and Monoclonal Antibodies
- 2.5 Regulation of IVD Products
- 2.5.1 Regulation of IVD in the US
- 2.5.2 Regulation of IVD in the EU
- 2.5.3 Regulation of Laboratory Developed Tests
3. The Global Immunochemistry Market, 2019-2029
- 3.1 Global Immunochemistry Market: Segment Analysis, 2018
- 3.2 Global Immunochemistry Market Forecast, 2019-2029
- 3.3. Global Immunochemistry Market Trends, 2019-2029
- 3.3.1 High Demand Due to Increase in Chronic Disease Patient Population
- 3.3.2 Automation of Laboratory Systems
- 3.3.3 Shift Towards Decentralisation
- 3.3.4 Industry Consolidation
- 3.3.5 Investments by Private Equity/Venture Capital
- 3.3.6 Increased Awareness through Globalisation
- 3.4. Immunochemistry Market: Drivers and Restraints, 2019-2029
4. Global Immunochemistry Reagents and Test Kits Market, 2019-2029
- 4.1. Introduction to Immunochemistry Reagents and Test Kits
- 4.2 Global Immunochemistry Reagents and Test Kits Market by Segment, 2018
- 4.3 Global Immunochemistry Reagents and Test Kits Market Forecast by Segment, 2019-2029
- 4.4 Disease Specific Tests Market
- 4.4.1 Disease Specific Tests Market by Segment, 2018
- 4.4.2 Disease Specific Tests Market Forecast by Segment, 2019-2029
- 4.4.3 Disease Specific Tests Market: Drivers and Restraints, 2019-2029
- 4.4.4 Infectious Diseases
- 4.4.4.1 Prevalence of Infectious Diseases
- 4.4.4.2 Infectious Disease Tests Market Forecast 2019-2029
- 4.4.4.3 Infectious Disease Tests Market Trends, 2019-2029
- 4.4.5 Autoimmune Diseases
- 4.4.5.1 Autoimmune Disease Tests Market Forecast 2019-2029
- 4.4.5.2 Autoimmune Disease Tests Market Trends, 2019-2029
- 4.4.6 Cancer and Tumour Markers
- 4.4.6.1 What are Tumour Markers?
- 4.4.6.1.1 Common Tumour Markers
- 4.4.6.2 Tumour Marker Market Forecast 2019-2029
- 4.4.6.3 Tumour Marker Market Trends, 2019-2029
- 4.4.7 Cardiovascular Diseases and Cardiac Markers
- 4.4.7.1 Prevalence of Cardiovascular Diseases
- 4.4.7.2 Common Cardiac Markers
- 4.4.7.3 Cardiac Marker Market Forecast 2019-2029
- 4.4.7.4 Cardiac Marker Market Trends, 2019-2029
- 4.4.8 Allergic Blood Tests
- 4.4.8.1 Prevalence of Allergy
- 4.4.8.2 Allergic Blood Tests Market Forecast 2019-2029
- 4.4.8.3 Allergic Blood Tests Market Trends, 2019-2029
- 4.4.8.4 Leading Allergy Testing Auto-Analysers
- 4.4.8.5 Allergy Blood Testing Dominated by Phadia (Part of Thermo Fisher)
- 4.5 Rapid Tests
- 4.5.1 Rapid Tests Market, 2018
- 4.5.2 Rapid Tests Market Forecast 2019-2029
- 4.5.3 Rapid Tests Market Trends, 2019-2029
- 4.5.4 Rapid Tests Market: Drivers and Restraints, 2019-2029
- 4.6 Drugs of Abuse
- 4.6.1 Extent of Illicit Drug Use
- 4.6.2 Common Drugs of Abuse
- 4.6.3 Drugs of Abuse/Toxicology Tests Market Forecast, 2019-2029
- 4.6.4 Drugs of Abuse/Toxicology Tests Market Trends, 2019-2029
- 4.6.5 Drugs of Abuse Tests Market: Drivers and Restraints, 2019-2029
- 4.7 Endocrinology Tests Market, 2018
- 4.7.1 Endocrinology Tests Market Forecast by Segment, 2019-2029
- 4.7.2 Trends in the Endocrinology Tests Market, 2019-2029
- 4.7.3 Endocrinology Tests Market: Drivers and Restraints, 2019-2029
- 4.8 Therapeutic Drug Monitoring
- 4.8.1 Commonly Monitored Drugs
- 4.8.1.1 Antiepileptics
- 4.8.1.2 Antiarrhythmics
- 4.8.1.3 Antibiotics
- 4.8.1.4 Immunosuppressants
- 4.8.1.5 Bronchodilators
- 4.8.1.6 Antimanics
- 4.8.2 Therapeutic Drug Monitoring Market, 2018
- 4.8.3 Immunoassays Preferred Over Chromatographic Methods for TDM
- 4.8.4 Therapeutic Drug Monitoring Market Forecast 2019-2029
- 4.8.5 Therapeutic Drug Monitoring Market Trends, 2019-2029
- 4.8.6 Therapeutic Drug Monitoring Market: Drivers and Restraints, 2019-2029
- 4.9 Anaemia/Vitamin Tests Market, 2018
- 4.9.1 What is Anaemia?
- 4.9.2 Types of Anaemia
- 4.9.2.1 Iron Deficiency Anaemia (IDA)
- 4.9.2.2 Vitamin Deficiency in Anaemia
- 4.9.3 Diagnosis of Vitamin B12 Deficiency and Folic Acid Deficiency
- 4.9.4 Vitamin D Deficiency Affects a Large Population Worldwide
- 4.9.5 Diagnosis of Vitamin D Deficiency
- 4.9.5.1 Immunoassays for Vitamin D Measurement
- 4.9.6 Anaemia/ Vitamin Tests Market Forecast 2019-2029
- 4.9.7 Anaemia/Vitamin Tests Market Trends, 2019-2029
- 4.9.8 Regulatory Approvals
- 4.9.9 Anaemia/Vitamin Tests Market: Drivers and Restraints, 2019-2029
5. Global Immunochemistry Analysers Market, 2019-2029
- 5.1 Introduction to Immunochemistry Analysers
- 5.1.1 Radioimmunoassay Analysers
- 5.1.2 Enzyme Immunoassay Analysers
- 5.1.3 Immunofluorescence Analysers
- 5.1.4 Chemiluminescence Analysers
- 5.2 Immunochemistry Analysers Market, 2018
- 5.3 Immunochemistry Analysers Market Forecast by Segment, 2019-2029
- 5.4 Immunochemistry Analysers Market Trends, 2019-2029
6. Regional Immunochemistry Markets, 2019-2029
- 6.1 Regional Breakdown of the Global Immunochemistry Market, 2018
- 6.2 Global Immunochemistry Market: Regional Forecast, 2019-2029
- 6.3 The North America Market
- 6.3.1 The North America Market: Growth Drivers
- 6.3.1.1 Increasing Prevalence of Chronic Diseases
- 6.3.1.2 Strong Growth in the Drugs of Abuse Market
- 6.3.2 The North America Market: Growth Restraints
- 6.3.2.1 Medical Device Excise Tax
- 6.3.3 North America Immunochemistry Reagents & Test Kits and Analysers Market: 2019-2029
- 6.3.4 North America Immunochemistry Market by National Market, 2019-2029
- 6.3.4.1 The U.S.
- 6.3.4.2 Canada
- 6.4 The European Market
- 6.4.1 Europe Immunochemistry Reagents & Test Kits and Analysers Market: 2019-2029
- 6.4.2 Europe Immunochemistry Market by National Market: 2019-2029
- 6.4.2.1 Germany and France
- 6.4.2.2 Italy
- 6.4.2.3 Spain
- 6.4.2.4 The UK
- 6.5 The Asia-Pacific Market
- 6.5.1 Asia-Pacific Immunochemistry Reagents & Test Kits and Analysers Market: 2019-2029
- 6.5.2 Asia-Pacific Immunochemistry Market by National Market: 2019-2029
- 6.5.2.1 Japan
- 6.5.2.2 China
- 6.5.2.3 India
- 6.6 The Latin American Market
- 6.6.1 Latin America Immunochemistry Reagents & Test Kits and Analysers Market: 2019-2029
- 6.6.2 Latin America Immunochemistry Market by National Market: 2019-2029
- 6.6.2.1 Brazil
- 6.6.2.2 Mexico
- 6.7 The Middle East & Africa Market
- 6.7.1 Middle East and Africa Immunochemistry Reagents & Test Kits and Analysers Market: 2019-2029
- 6.7.2 Middle East and Africa Immunochemistry Market, by National Markets: 2019-2029
- 6.7.2.1 South Africa
- 6.7.2.2 GCC Countries
7. Leading Companies in the Immunochemistry Market
- 7.1 F. Hoffmann-La Roche AG
- 7.1.1 Sales and Performance Analysis
- 7.1.2 Roche Diagnostics
- 7.1.3 Investment in Research and Development
- 7.1.4 Historical Product Launches in the Immunochemistry Market
- 7.1.5 Construction of New Diagnostic Production Facility
- 7.1.6 Roche: Immunochemistry Analysers
- 7.1.6.1 Cobas 8000 Analyser
- 7.1.6.2 Cobas 6000 Analyser
- 7.1.6.3 Cobas 4000 Analyser
- 7.2 Siemens AG
- 7.2.1 Sales and Performance Analysis
- 7.2.2 Siemens Healthcare Sector
- 7.2.3 Siemens: R&D Expenses
- 7.2.4 Siemens: Immunochemistry Analysers
- 7.2.4.1 Dimension Vista Systems
- 7.2.4.2 Advia Centaur XP Immunoassay System
- 7.2.4.3 Advia Centaur CP Immunoassay System
- 7.2.4.4 Immulite Series
- 7.2.4.4.1 Immulite 2000 Immunoassay System
- 7.2.4.4.2 Immulite 1000 Immunoassay System
- 7.3 Abbott Laboratories
- 7.3.1 Sales and Performance Analysis
- 7.3.2 Abbott: Immunochemistry Analysers
- 7.3.2.1 Abbott Prism
- 7.3.2.2 Architect ci8200
- 7.3.2.3 Architect ci16200
- 7.3.2.4 Architect ci4100
- 7.4 Danaher Corporation
- 7.4.1 Sales and Performance Analysis
- 7.4.2 Life Sciences & Diagnostics
- 7.4.3 Danaher: Immunochemistry Analysers
- 7.5 bioMérieux
- 7.5.1 Sales and Performance Analysis
- 7.5.3 bioMérieux: Recent Collaborations
- 7.5.3.1 Collaboration with Royal Philips Electronics
- 7.5.3.2 Collaboration with Hospices Civils De Lyon
- 7.6 Ortho Clinical Diagnostics (part of Carlyle Group L.P.)
- 7.6.1 Sales and Performance Analysis (Carlyle Group L.P.)
- 7.6.2 Ortho Clinical Diagnostics: Immunodiagnostic Analysers
- 7.7 Thermo Fisher Scientific
- 7.7.1 Sales and Performance Analysis
- 7.7.2 Thermo Fisher: Immunodiagnostic Analysers
- 7.8 Sysmex Corporation
- 7.8.1 Sales and Performance Analysis
- 7.8.2 Sysmex Corporation: Immunodiagnostic Analysers
- 7.9 Fujirebio
- 7.9.1 Fujirebio: Immunodiagnostic Analysers
- 7.10 Trivitron Healthcare Pvt. Ltd.
- 7.10.1 Trivitron Healthcare Pvt. Ltd.: Immunodiagnostic Analysers
8. SWOT Analysis of the Immunochemistry Market, 2019-2029
- 8.1 Strengths
- 8.1.1 Patient Demographics
- 8.1.2 Automation and Other Technological Advancements
- 8.1.3 IVD Tests are Vital for Disease Management
- 8.1.4 Mature Market
- 8.2 Weaknesses
- 8.2.1 Regulatory Board Approval
- 8.2.2 Reimbursement Issues
- 8.3 Opportunities
- 8.4 Threats
- 8.4.1 Medical Device Excise Tax
- 8.4.2 Regulatory Issues - Lack of Clarity Can be Costly
9. Conclusions
- 9.1 The Immunochemistry Market - Driven by the Reagents and Test Kits Market
- 9.2 Rapid Tests Will Remain the Fastest Growing Segment
- 9.3 The US was the Leading National Market in 2018
- 9.4 Future Outlook and Concluding Remarks
Appendices
- Associated Visiongain Reports
- Visiongain Report Sales Order Form
- About Visiongain
- Visiongain report evaluation form